Literature DB >> 21784352

Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants.

David S Wald1, Anuradhani Kasturiratne, Mark Simmonds.   

Abstract

BACKGROUND: Prospective cohort studies have not been consistent in showing an association between serum homocysteine and dementia.
OBJECTIVE: To conduct a meta-analysis of cohort studies that examined the relationship between serum homocysteine and dementia, and to estimate the change in risk of dementia for a unit change in serum homocysteine.
METHODS: The data from eight cohort studies (involving 8,669 participants; range of mean ages, 47-81 years; median duration of study, 5 years) of serum homocysteine on the incidence of dementia were combined and the odds ratio of dementia per 5 μmol/L increase in serum homocysteine was determined.
RESULTS: There was a statistically significant association between serum homocysteine and the incidence of dementia: the odds ratio for a 5 μmol/L increase in serum homocysteine was 1.35 (95% confidence interval, 1.02-1.79) or 1.50 (1.13-2.00) adjusted for regression dilution bias. The odds ratio for a 3 μmol/L decrease in serum homocysteine (the average reduction expected using folic acid and B12) was 0.78 (0.66-0.93).
CONCLUSION: The meta-analysis of epidemiological cohort studies shows a positive association between serum homocysteine and dementia. Although the results do not provide evidence of cause and effect, they do provide an estimate of the expected effect if the relationship were causal; an approximate 20% reduction in risk of dementia from treatment with folic acid and B12. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784352     DOI: 10.1016/j.jalz.2010.08.234

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  35 in total

1.  Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.

Authors:  Sungeun Kim; Kwangsik Nho; Vijay K Ramanan; Dongbing Lai; Tatiana M Foroud; Katie Lane; Jill R Murrell; Sujuan Gao; Kathleen S Hall; Frederick W Unverzagt; Olusegun Baiyewu; Adesola Ogunniyi; Oye Gureje; Mitchel A Kling; P Murali Doraiswamy; Rima Kaddurah-Daouk; Hugh C Hendrie; Andrew J Saykin
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

2.  Natural folates from biofortified tomato and synthetic 5-methyl-tetrahydrofolate display equivalent bioavailability in a murine model.

Authors:  Fabiola Castorena-Torres; Perla A Ramos-Parra; Rogelio V Hernández-Méndez; Andrés Vargas-García; Gerardo García-Rivas; Rocío I Díaz de la Garza
Journal:  Plant Foods Hum Nutr       Date:  2014-03       Impact factor: 3.921

3.  Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells.

Authors:  M Currò; A Gugliandolo; C Gangemi; R Risitano; R Ientile; D Caccamo
Journal:  Neurochem Res       Date:  2014-05-28       Impact factor: 3.996

4.  Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Sarah K Madsen; Priya Rajagopalan; Shantanu H Joshi; Arthur W Toga; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2014-08-30       Impact factor: 4.673

5.  Plasma total homocysteine is associated with DNA methylation in patients with schizophrenia.

Authors:  Makoto Kinoshita; Shusuke Numata; Atsushi Tajima; Shinji Shimodera; Issei Imoto; Tetsuro Ohmori
Journal:  Epigenetics       Date:  2013-04-26       Impact factor: 4.528

6.  Development of AD-Like Pathology in Skeletal Muscle.

Authors:  X Chen; N M Miller; Z Afghah; J D Geiger
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2019-04-02

7.  Homocysteine levels and dementia risk in Yoruba and African Americans.

Authors:  Hugh C Hendrie; Olusegun Baiyewu; Kathleen A Lane; Christianna Purnell; Sujuan Gao; Ann Hake; Adesola Ogunniyi; Oye Gureje; Frederick W Unverzagt; Jill Murrell; Mark A Deeg; Kathleen Hall
Journal:  Int Psychogeriatr       Date:  2013-07-30       Impact factor: 3.878

Review 8.  Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.

Authors:  Sasanka Chakrabarti; Vineet Kumar Khemka; Anindita Banerjee; Gargi Chatterjee; Anirban Ganguly; Atanu Biswas
Journal:  Aging Dis       Date:  2015-08-01       Impact factor: 6.745

9.  Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.

Authors:  Gwenaëlle Douaud; Helga Refsum; Celeste A de Jager; Robin Jacoby; Thomas E Nichols; Stephen M Smith; A David Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

10.  Intake of niacin, folate, vitamin B-6, and vitamin B-12 through young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Bo Qin; Pengcheng Xun; David R Jacobs; Na Zhu; Martha L Daviglus; Jared P Reis; Lyn M Steffen; Linda Van Horn; Stephen Sidney; Ka He
Journal:  Am J Clin Nutr       Date:  2017-08-02       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.